Peganine hydrochloride dihydrate an orally active antileishmanial agent
Protozoic infections caused by genus Leishmania pose an enormous public health threat in developing countries, compounded by the toxicity and resistance to current therapies. Under the aegis of our ongoing program on drug discovery and development on antileishmanial agents from plants, we carried ou...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 19; no. 9; pp. 2585 - 2586 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ltd
01.05.2009
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Protozoic infections caused by genus
Leishmania pose an enormous public health threat in developing countries, compounded by the toxicity and resistance to current therapies. Under the aegis of our ongoing program on drug discovery and development on antileishmanial agents from plants, we carried out bioassay guided fractionation on
Peganum harmala seeds which resulted in the isolation of
1 as an antileishmanial agent. 2D-NMR spectral data and single crystal X-ray crystallography data indicated
1 as peganine hydrochloride in dihydrated form. The compound
1 exhibited in-vitro activity against both extracellular promastigotes as well as intracellular amastigotes residing within murine macrophages in
Leishmania donovani. Furthermore,
1 also exhibited in-vivo activity, 79.6 (±8.07)% against established VL in hamsters at a dose of 100
mg/kg
b.wt. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.03.039 |